Post-Artesunate Delayed Hemolysis: A Review of Current Evidence

Artesunate is the drug of choice for treating patients with severe malaria. Post-artesunate delayed hemolysis (PADH) is an uncommon adverse event from malaria treatment. Most patients with PADH are non-immune travelers. The pathophysiology of PADH is not fully understood, but the most likely mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaita, Sawettachai, Madsalae, Krit, Charoensakulchai, Sakarn, Hanboonkunapakarn, Borimas, Chotivanit, Kesinee, McCarthy, Anne E., Matsee, Wasin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862382/
https://www.ncbi.nlm.nih.gov/pubmed/36668956
http://dx.doi.org/10.3390/tropicalmed8010049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862382/
https://www.ncbi.nlm.nih.gov/pubmed/36668956
http://dx.doi.org/10.3390/tropicalmed8010049

Ejemplares similares